CORONAVIRUS (COVID-19)
![HOPA guests walking wearing masks](/media/original_images/081_HOPA_2022_Conference_in_Boston_-_Registration_Signage__Networking.jpg.960x429_q88_crop_focal_area-3096%2C2064%2C6192%2C4128_size_canvas_upscale_zoom-100.jpg)
HOPA has been closely monitoring the coronavirus and its impact on the pharmacist community. As a most-valued front-line responder, HOPA is committed to connecting you to the most current resources and information you need to support your patients.
Resources – Cancer Patients
- NCI COVID-19 Patient Resources
- ASCO COVID-19 Patient Care Information
- ASCO Cancer.Net Patient Information
- ACS COVID-10 and Cancer
- ONS COVID-19 Patient Care Resources
Resources – Healthcare Providers
Pharmacist
- APhA: Pharmacists’ Guide to Coronavirus
- ASHP COVID-19 Resource Center
- ACCP COVID-19 Updates
- Pharmacy Times Coronavirus Resource Center
- Editorial: Role of the Clinical Pharmacist during COVID-19
- ASHP Drug Shortages
Oncology
- ASCO Coronavirus Resources
- NCCN COVID-19 Resources
- ESMO – COVID-19 and Cancer
- ONS COVID-19 Resources
- NCI Guidance for Researchers
Advocacy
- Sign-on Letters
- COVID-19 Legislation Explained
- Phase I-Coronavirus Preparedness and Response Supplemental Appropriations Act
- Phase II-Families First Coronavirus Response Act
- Phase III-Coronavirus Aid, Relief, and Economic Security (CARES) Act
- Phase III-Summary of Economic Provisions in the CARES Act
- Summary of Paycheck Protection Program and Health Care Enhancement Act (“COVID 3.5”)